EUVIMEDEUVIMED entdecken
Crossref

Ultrahypofractionated Whole Breast Irradiation in Early-Stage Breast Cancer: An Italian Multicenter Observational Study

Isabella Palumbo, Anna Giulia Becchetti, Elisa D'Angelo, Maria Carmen De Santis, Alessandra Fozza, Grazia Lazzari, Sara Falivene, Antonella Baldissera, Gianluca Ingrosso, Francesca De Felice, Marianna Nuzzo, Paola Anselmo und 22 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-07

DOI: 10.1016/j.ijrobp.2026.07.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-07. Verfasst von Isabella Palumbo und 33 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Unit, Perugia General Hospital, Perugia, Italy; Department of Civil and Environmental Engineering, University of Perugia, Perugia,…. Die Arbeit nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: In patients who received breast-conserving surgery for early-stage breast cancer, the present study assessed acute and short-term side effects and oncological outcomes after whole breast irradiation (WBI) with an ultrahypofractionated schedule. METHODS AND MATERIALS: From 2020 to 2025, 2036 patients (median age 70 years; range, 19-93) were recruited from 28 Italian Radiation Oncology Centers. Inclusion criteria included: early-stage breast cancer (either invasive or ductal in situ carcinomas), age ≥ 18 years, breast-conserving surgery and delivery of ultrahypofractionated WBI by means of any radiation therapy (RT) technique. All patients received 26 Gy in 5 consecutive fractions of 5.2 Gy. Depending on risk factors for local relapse, some patients received a sequential or simultaneous integrated boost. Side effects were monitored at diverse time points for ≤2 years. RESULTS: Median follow-up was 12 months (range, 1-55). The incidence of side effects was low, and they were mainly G1. The most frequent acute side effect (37.1%) was erythema, 90.2% were G1. Skin hyperpigmentation, the most frequent short-term late side effect, occurred in 12.2% of patients (95.7% G1) at 6 months, in 5.7% (98.4% G1) at 12 months, 5.7% (96% G1) at 18 months, and 4% (100% G1) at 24 months after the end of RT. In multivariate analysis, significant factors for acute side effects were active smoking and boost administration. Furthermore, age emerged as a protective factor, while a larger breast planning target volume was associated with increased side effects. Significant risk factors for late side effects were active smoking at +6 months and a larger planning target volume boost at +6 and +12 months after the end of RT. CONCLUSIONS: In our large series of patients with early-stage breast cancer, ultrahypofractionated WBI appeared safe and feasible.

Autor:innen und Institutionen

  • Radiation Oncology Unit, Perugia General Hospital, Perugia, Italy; Department of Civil and Environmental Engineering, University of Perugia, Perugia, Italy. Electronic address: isabella.palumbo@unipg.it.
  • Radiation Oncology Unit, Perugia General Hospital, Perugia, Italy.
  • Radiation Oncology Department, Bellaria Hospital, AUSL Bologna, Italy.
  • Radiation Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Radiation Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Radiation Oncology Unit, IRCCS-CROB, Rionero in Vulture, Potenza, Italy.

Zitieren

APA

Palumbo, I., Becchetti, A. G., D'Angelo, E., De Santis, M. C., Fozza, A., Lazzari, G., Falivene, S., Baldissera, A., Ingrosso, G., De Felice, F., Nuzzo, M., Anselmo, P., Marazzi, F., Carnevale, M. G., Blandino, G., Musu, A. R., Cucciarelli, F., Rago, L., Andrulli, A. D., …, & Aristei, C. (2026). Ultrahypofractionated Whole Breast Irradiation in Early-Stage Breast Cancer: An Italian Multicenter Observational Study. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.07.003

Vancouver

Palumbo I, Becchetti AG, D'Angelo E, De Santis MC, Fozza A, Lazzari G, et al. Ultrahypofractionated Whole Breast Irradiation in Early-Stage Breast Cancer: An Italian Multicenter Observational Study. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.07.003

BibTeX
@article{Palumbo2026,
  author = {Palumbo, Isabella and Becchetti, Anna Giulia and D'Angelo, Elisa and De Santis, Maria Carmen and Fozza, Alessandra and Lazzari, Grazia and Falivene, Sara and Baldissera, Antonella and Ingrosso, Gianluca and De Felice, Francesca and Nuzzo, Marianna and Anselmo, Paola and Marazzi, Fabio and Carnevale, Maria Grazia and Blandino, Gladys and Musu, Anna Rita and Cucciarelli, Francesca and Rago, Luciana and Andrulli, Angela Damiana and Mascioni, Francesca and Ferraioli, Piera and Macchia, Gabriella and Antonello, Michele and Prisco, Agnese and La Rocca, Eliana and Alessandro, Marina and Fiorentino, Alba and Fontana, Antonella and Barbara, Raffaele and Bacchiddu, Simonetta and Bonzano, Elisabetta and Campoccia, Salvatrice and Bini, Vittorio and Aristei, Cynthia},
  title = {Ultrahypofractionated Whole Breast Irradiation in Early-Stage Breast Cancer: An Italian Multicenter Observational Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.07.003}
}
Kostenlos starten →